What happens if you fall pregnant on Mounjaro

Step 1: Stop Mounjaro and contact a clinician the same day

If a pregnancy test comes back positive while you are on Mounjaro, the first step is to stop injecting and speak to your GP or midwife that day. This is not a situation for waiting to see how things go. Tirzepatide is not licensed for use in pregnancy, and the prescriber who oversees your treatment will need to be told too, so your records are updated and any repeat orders are paused.

The reason the guidance is this firm is straightforward: animal studies showed developmental effects at doses relevant to those used in humans, and there is simply no adequate safety data in pregnant women. Regulators and clinicians follow a precautionary principle when that evidence gap exists. You can read the underlying product information in the Mounjaro SmPC on the eMC, which sets out the contraindication in plain terms.

It is also worth checking, right now if you have a pen at home, how long your Mounjaro pen remains usable outside the fridge, and whether your next scheduled dose is due within the next few days; cancelling it before it goes in is better than a call afterwards. That single minute's check can matter.

Step 2: Understand what is (and is not) known about the risks

There is no large registry of human pregnancies exposed to tirzepatide to draw on, because the medicine is relatively new and weight-loss treatment is paused when pregnancy is confirmed. What exists are the preclinical (animal) data. Studies in rats and rabbits showed reduced fetal weight and skeletal abnormalities at exposures that overlapped with therapeutic levels. These findings do not translate automatically to humans, but they are serious enough that no regulator has cleared the medicine for pregnant women.

Weight loss itself, driven by a significant calorie deficit, carries separate risks in early pregnancy, adequate nutrition and folic acid intake matter enormously during the first trimester. Your midwife or GP will want to assess your nutritional status as part of early antenatal care. The NHS tirzepatide medicines page summarises the key points on pregnancy and other situations where Mounjaro is not suitable.

If you had only a brief exposure (say, one or two injections at the 2.5 mg starting dose before discovering the pregnancy) that context is still worth sharing with your clinician, who can give you a more personalised picture, including what happens if you get pregnant on Mounjaro at different stages of treatment. Honest disclosure makes for better care.

Step 3: Think about contraception before any future treatment

For women who stop Mounjaro because of pregnancy and later want to resume treatment, or for those currently on treatment who want to plan a future pregnancy, the contraception guidance is specific. The MHRA advises using reliable contraception throughout treatment. For women on oral contraceptives, there is an additional practical step: because Mounjaro slows how quickly the stomach empties, the absorption of swallowed medicines (including the pill) may be reduced. UK guidance, covered in detail on the NHS England weight management injections page, is to add a non-oral method such as condoms for the first four weeks of Mounjaro treatment and for four weeks after every dose increase.

When it comes to trying to conceive, the MHRA advises stopping Mounjaro beforehand and waiting for a wash-out period, the prescriber can advise on the appropriate interval based on current guidance and your individual circumstances. This is not a decision to make alone or in a hurry. Our clinical team fields questions like this regularly, and a consultation is the right place to work through the timing.

If you are reading this page at the planning stage rather than in a panic after a positive test, that is the best position to be in. Raising it before starting treatment means the prescriber can factor it into your care from day one. More on how we approach each step of treatment is on our Mounjaro overview page.

Who else needs to know, and what happens next with weight management

Beyond your GP and midwife, tell your pharmacist if you collect any other medicines; some interactions that were managed during Mounjaro treatment will need fresh review now that the medicine is stopped. If you were on a titrated dose well above 2.5 mg, do not assume the transition off the medicine is without effect, appetite and blood sugar patterns can shift as tirzepatide clears the body over several weeks, and what happens after stopping Mounjaro is worth understanding so you are not caught off guard by a returning appetite.

Weight management during pregnancy is led by your midwifery and obstetric team, not by prescription medicines. After pregnancy and any period of breastfeeding (during which Mounjaro is also not recommended) the question of whether to resume treatment is one to raise with your GP or a clinician at a service like ours. The landscape of licensed weight-loss treatments may have changed by then, and a fresh assessment will give you the most accurate picture of what is suitable.

If you were mid-way through a titration and found the treatment was working well, that progress does not disappear. Many people return to treatment successfully after the postnatal period, and it is useful to understand what happens if you over eat on Mounjaro so you can manage the restart confidently. The effects Mounjaro has on appetite and metabolism are well documented in trial data, and a clinician can help you plan a return to treatment when the time is right. In the meantime, if you have any questions about how to contact our team, we are available seven days a week.